Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-29

Clinical Trial Update: The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis [Phase 3]

View source ↗

Summary

Phase 3 trial update for apixaban in treating calf vein thrombosis (a form of deep vein thrombosis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apixaban (apixaban)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Deep Vein Thrombosis | Phase 3 | Status: NOT_YET_RECRUITING